Duchenne Muscular Dystrophy  >>  Duvyzat (givinostat)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duvyzat (givinostat) / Italfarmaco
NCT03238235 / 2017-001629-41: Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy

Completed
2
51
Europe
givinostat, Active Comparator: givinostat, placebo, Placebo Comparator: placebo
Italfarmaco
Becker Muscular Dystrophy
03/21
03/21
NCT01761292 / 2012-002566-12: A Study to Assess Safety/Tolerability, pk, Effects on Histology, Clinical Parameters of Givinostat in Children With DMD

Completed
1/2
20
Europe
Givinostat, ITF2357
Italfarmaco
Duchenne Muscular Dystrophy (DMD)
12/14
11/17

Download Options